Updated:
Asclepius Life Sciences
Asclepius Life Sciences runs the Asclepius Life Sciences Fund, LP with focus on life sciences venture and buyout deals.
Asclepius Life Sciences
Asclepius Life Sciences is a New York-based investment company focused on Buyout strategies. The firm has a team of three staff, including three investment professionals.
General information
Firm type
Generalist
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Additional offices
Weston, FL, United States
Principals
Stephen C. Glover
Co-Founder and Managing Principal
Michael Levas
Co-Founder and Managing Principal
Dr. Steven Guest
Principal
Sector focus
Frequently asked questions
Who runs investment decisions at Asclepius Life Sciences?
Stephen C. Glover and Michael Levas serve as co-founders and managing principals. Dr. Steven Guest acts as principal. Marissa Fayer participates as a business partner with board roles at portfolio companies.
Does Asclepius Life Sciences participate in fund commitments or only direct deals?
The firm operates the Asclepius Life Sciences Fund, LP. Available records show both venture commitments and direct involvement through SPAC structures such as Larkspur Health Acquisition Corp.
Where does the underlying wealth come from?
No public disclosure identifies the source of capital for the Asclepius Life Sciences Fund, LP.
What investment stages does Asclepius Life Sciences typically target?
Records list buyout, early-stage seed, start-up, expansion, and general venture activity.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: